MabCure, Inc.
MBCI · OTC
12/31/2011 | 9/30/2011 | 6/30/2011 | 3/31/2011 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.17 | -0.62 | 0.42 |
| FCF Yield | 3.24% | -0.96% | 0.05% | -0.60% |
| EV / EBITDA | -0.41 | -34.08 | -45.60 | -68.91 |
| Quality | ||||
| ROIC | 5.48% | -1.80% | -2.59% | -2.64% |
| Gross Margin | 100.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | – | – | – | 0.33 |
| Growth | ||||
| Revenue 3-Year CAGR | 793,600.53% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 276.73% | -1,287.34% | 105.27% | -33.17% |
| Safety | ||||
| Net Debt / EBITDA | -0.01 | -1.00 | -0.75 | -0.14 |
| Interest Coverage | 18.10 | -29.81 | -3.13 | -5.53 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |